World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
25555
World Ranking
2230
National Ranking
925

Susan H. Eshleman publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Susan H. Eshleman sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 272 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Susan H. Eshleman D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Susan H. Eshleman sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 67 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Susan H. Eshleman is affiliated with Johns Hopkins University School of Medicine in the United States. Their research primarily focuses on medicine, immunology, and microbiology, with a strong specialization in infectious diseases and virology.

The scientist's work extensively covers topics related to HIV/AIDS research and interventions, including HIV research and treatment, drug development and treatment for HIV/AIDS, and aspects of HIV related to drug use and sexual risk. Their interests also include HIV-related health complications and treatments, as well as SARS-CoV-2 detection and testing, and adolescent sexual and reproductive health.

Frequent publication venues for their work include:

  • UNC Libraries
  • Journal of the International AIDS Society
  • The Lancet HIV
  • PLoS ONE
  • The Journal of Infectious Diseases

Key recent publications by Susan H. Eshleman include:

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women, 2021, New England Journal of Medicine
  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial, 2022, The Lancet
  • Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial, 2020, The Lancet HIV
  • Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083, 2021, The Journal of Infectious Diseases
  • Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality, 2021, Journal of Clinical Investigation

Among frequent collaborators, Susan H. Eshleman has worked closely with Estelle Piwowar-Manning, Myron S. Cohen, Deborah Donnell, Marybeth McCauley, and Beatriz Grinsztejn, contributing to multiple publications alongside these coauthors.

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Beatriz Grinsztejn;Mina C. Hosseinipour;Heather J. Ribaudo;Susan Swindells

  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

    Unknown

  • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

    Susan H. Eshleman;Martin Mracna;Laura A. Guay;Martina Deseyve

  • Effect of universal testing and treatment on HIV incidence - HPTN 071 (popart)

    Richard J Hayes;Deborah Donnell;Sian Floyd;Nomtha Mandla

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

    Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  • Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

    J. B. Jackson;G. Becker-Pergola;L. A. Guay;P. Musoke

  • The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial

    Audrey Pettifor;Catherine MacPhail;Catherine MacPhail;James P Hughes;James P Hughes;Amanda Selin

  • Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012

    Tamara Flys;Dwight V. Nissley;Cassidy W. Claasen;Dana Jones

  • Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure

    Paul Palumbo;Jane C. Lindsey;Michael D. Hughes;Mark F. Cotton

  • Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.

    Avy Violari;Jane C. Lindsey;Michael D. Hughes;Hilda A. Mujuru

  • Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.

    Kenneth H Mayer;Kenneth H Mayer;Kenneth H Mayer;Lisa A Maslankowski;Fang Gai;Wafaa M El-sadr

  • Nevirapine (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP

    Susan H. Eshleman;Donald R. Hoover;Shu Chen;Sarah E. Hudelson

  • Correlates of HIV acquisition in a cohort of black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061

    Beryl A. Koblin;Kenneth H. Mayer;Susan H. Eshleman;Lei Wang

  • Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

    Wei Huang;Susan H. Eshleman;Jonathan Toma;Signe Fransen

  • Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

    Hoosen M Coovadia;Hoosen M Coovadia;Elizabeth R Brown;Mary Glenn Fowler;Tsungai Chipato

  • Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial.

    Thomas J Coates;Michal Kulich;David D Celentano;Carla E Zelaya

  • Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

    Raphael J. Landovitz;Sue Li;Beatriz Grinsztejn;Halima Dawood

  • Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities.

    Kenneth H. Mayer;Lei Wang;Beryl Koblin;Sharon Mannheimer

  • LigAmp for sensitive detection of single-nucleotide differences

    Chanjuan Shi;Susan H Eshleman;Dana Jones;Noriyoshi Fukushima

Frequent Co-Authors

Oliver Laeyendecker
Oliver Laeyendecker Johns Hopkins University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
J. Brooks Jackson
J. Brooks Jackson University of Iowa Hospitals and Clinics
Deborah Donnell
Deborah Donnell Fred Hutchinson Cancer Research Center
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
James P. Hughes
James P. Hughes University of Washington
Myron S. Cohen
Myron S. Cohen University of North Carolina at Chapel Hill
Taha E. Taha
Taha E. Taha Johns Hopkins University
Mary Glenn Fowler
Mary Glenn Fowler Johns Hopkins University
Beatriz Grinsztejn
Beatriz Grinsztejn Oswaldo Cruz Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities in the healthcare and research sectors. One popular pathway is becoming a Certified Professional Coder, which requires obtaining a certified professional coder certification. This certification is essential for those looking to work with medical coding, billing, and healthcare documentation.

Another promising field linked to microbiology is Health Information Management. Professionals in this sector manage healthcare data and patient records, combining clinical knowledge with technology. The demand and compensation for these roles can be reviewed by exploring health information management jobs salary insights.

For those seeking academic qualifications, selecting from the best cahiim accredited him programs online ensures the education received meets industry standards and increases job market readiness.

Lastly, individuals eager to start quickly in the medical field can consider taking online medical billing and coding certificate fast programs. These fast-tracked options provide vital skills and certifications, paving the way to enter healthcare administration with minimal delay.

Best Scientists Citing Susan H. Eshleman

Trending Scientists

Recently Published Articles